Patents by Inventor Daniel R Sylvester

Daniel R Sylvester has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
    Patent number: 7807793
    Abstract: Chimeric and humanized IL4 MAbs derived from affinity MAbs, pharmaceutical compositions containing same, and methods of treatment are provided.
    Type: Grant
    Filed: July 26, 2006
    Date of Patent: October 5, 2010
    Assignee: GlaxoSmithKline LLC
    Inventors: Stephen Dudley Holmes, Mitchell Stuart Gross, Daniel R. Sylvester
  • Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
    Publication number: 20020193575
    Abstract: Chimeric and humanized IL4 MAbs derived from affinity MAbs, pharmaceutical compositions containing same, and methods of treatment are provided.
    Type: Application
    Filed: June 12, 2001
    Publication date: December 19, 2002
    Applicant: SmithKline Beecham p.l.c.
    Inventors: Stephen Dudley Holmes, Mitchell Stuart Gross, Daniel R. Sylvester
  • BirA from staphylococcus aureus
    Patent number: 6448038
    Abstract: The invention provides birA polypeptides and polynucleotides encoding birA polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing birA polypeptides to screen for antibacterial compounds.
    Type: Grant
    Filed: January 26, 1999
    Date of Patent: September 10, 2002
    Assignee: SmithKline Beecham Corporation
    Inventors: Jianzhong Huang, Howard Kallender, Damien McDevitt, Stephanie Van Horn, Daniel R Sylvester
  • yneS
    Publication number: 20020058789
    Abstract: The invention provides yneS polypeptides and polynucleotides encoding yneS polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are preferred methods for utilizing yneS polypeptides and polynucleotides as diagnostic reagents and in diagnostic assaysto screen for microbial infections in organisms and materials.
    Type: Application
    Filed: March 30, 2001
    Publication date: May 16, 2002
    Inventors: Sanjoy Biswas, Martin K. R. Burnham, Damien McDevitt, Daniel R. Sylvester, Patrick V. Warren, Magdalena Zalacain
  • DNA encoding recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
    Patent number: 5928904
    Abstract: Chimeric and humanized IL4 MAbs derived from high affinity MAbs, pharmaceutical compositions containing same, and methods of treatment are provided.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: July 27, 1999
    Assignees: SmithKline Beecham Corporation, SmithKline Beecham P.L.C.
    Inventors: Stephen D. Holmes, Mitchell Stuart Gross, Daniel R. Sylvester
  • Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
    Patent number: 5914110
    Abstract: Chimeric and humanized IL4 MAbs derived from high affinity MAbs, pharmaceutical compositions containing same, and methods of treatment are provided.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: June 22, 1999
    Assignees: SmithKline Beecham Corporation, SmithKline Beecham p.l.c.
    Inventors: Stephen D. Holmes, Mitchell Stuart Gross, Daniel R. Sylvester